Multicentral Observational Prospective Cohort of Patients With Spontaneous Intracerebral Hemorrhage

De-zhi Kang6 sites in 1 country3,000 target enrollmentNovember 6, 2023

ConditionsStroke, Acute Intracerebral Hemorrhage

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Stroke, Acute
Sponsor: De-zhi Kang
Enrollment: 3000
Locations: 6
Primary Endpoint: Neurological Function
Status: Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.

Registry

clinicaltrials.gov

Start Date

November 6, 2023

End Date

December 30, 2028

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

De-zhi Kang

Responsible Party

Sponsor Investigator

Principal Investigator

De-zhi Kang

Prof.

First Affiliated Hospital of Fujian Medical University

Eligibility Criteria

Inclusion Criteria

•Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI);
•Underwent no surgical intervention;

Exclusion Criteria

•Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma)
•Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis)
•Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease)
•Unsuitable for inclusion in the study in the opinion of the investigator